NewsVivo Bio Tech Promoter Group Member Acquires 90,000 Equity Shares Through Warrant ConversionVivo Bio Tech Promoter Group Member Acquires 90,000 Equity Shares Through Warrant Conversion
Kompella Lopa Mudra, promoter group member of Vivo Bio Tech Limited, acquired 90,000 equity shares through warrant conversion on January 06, 2026. The transaction maintained total shareholding at 3.09% while restructuring the holding pattern between direct equity and warrants. The company's equity capital increased from ₹22.10 crores to ₹22.19 crores following the preferential allotment.
*this image is generated using AI for illustrative purposes only.
Vivo Bio Tech promoter group member Kompella Lopa Mudra has disclosed the substantial acquisition of 90,000 equity shares under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The acquisition was completed on January 06, 2026, through the conversion of warrants issued on preferential basis.
Transaction Details
The acquisition involved the allotment of 90,000 equity shares through warrant conversion, representing 0.40% of the company's total share capital and 0.38% of the diluted share capital. The transaction was executed through preferential allotment mechanism.
| Transaction Parameter: | Details |
|---|---|
| Shares Acquired: | 90,000 equity shares |
| Acquisition Date: | January 06, 2026 |
| Mode of Acquisition: | Warrant conversion on preferential basis |
| Share Value: | ₹10 per equity share |
| Acquirer Category: | Promoter Group |
Shareholding Pattern Changes
Following the acquisition, Kompella Lopa Mudra's shareholding structure has been restructured while maintaining the same total percentage holding. The conversion resulted in an increase in direct equity shareholding and a corresponding decrease in warrant holdings.
Before Acquisition:
| Holding Type: | Number of Shares | % of Total Capital | % of Diluted Capital |
|---|---|---|---|
| Equity Shares: | 2,43,333 | 1.10% | 1.03% |
| Warrants: | 4,40,000 | 1.99% | 1.86% |
| Total Holding: | 6,83,333 | 3.09% | 2.89% |
After Acquisition:
| Holding Type: | Number of Shares | % of Total Capital | % of Diluted Capital |
|---|---|---|---|
| Equity Shares: | 3,33,333 | 1.50% | 1.41% |
| Warrants: | 3,50,000 | 1.58% | 1.48% |
| Total Holding: | 6,83,333 | 3.09% | 2.89% |
Company Capital Structure
The transaction resulted in changes to Vivo Bio Tech Limited's equity share capital structure. The company's paid-up capital increased following the warrant conversion.
| Capital Structure: | Before Transaction | After Transaction |
|---|---|---|
| Equity Share Capital: | ₹22.10 crores | ₹22.19 crores |
| Number of Shares: | 2,21,00,628 shares | 2,21,90,628 shares |
| Diluted Share Capital: | - | ₹23.63 crores |
| Diluted Shares: | - | 2,36,28,520 shares |
Regulatory Compliance
The disclosure was made in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, specifically under Regulation 29(2). The filing was submitted to BSE Limited on January 08, 2026, where Vivo Bio Tech Limited shares are listed under scrip code 511509. The diluted share capital calculation assumes conversion of outstanding 14,37,892 warrants into equity shares in future tranches.
Historical Stock Returns for Vivo Bio Tech
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.90% | -5.55% | -16.52% | -27.34% | -27.34% | -27.34% |
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
